Levofloxacin

左氧氟沙星

Report date: 2026/05/26 20:00:28
NMEQIDP

Base Information

Drug NameLevofloxacin
Drug Alias Name左氟沙星左旋氧氟沙星Iquix可乐必妥Aeroquin +[19] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsBacterial DNA gyraseTopoisomerase IV
Therapy Area/IndicationsInhalational anthraxComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infections +[54] 
Global Approved IndicationsComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infectionsPyelonephritis +[15] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1996/12/20
Country/TerritoryCzechiaBelgiumCanada +[30] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesAvicenna Medical College LahoreUniversity Of ManitobaPolyactiva Pty Ltd +[8] 
Inactive CompaniesUniversity Of KarachiGlaxosmithkline PlcUniversity Of Rochester +[16] 
Active IndicationsFeverMyeloproliferative DisordersMyelodysplastic Syndromes +[17] 
Inactive IndicationsInhalational anthraxComplicated Skin and Soft Tissue InfectionsUncomplicated skin and skin structure infections +[37] 

Other Information

ATC CodeJ01MA12S01AE05
Related LinksWikipediaDrugBankKEGG